Goldenbridge Acquisition Limited (GBRG) to Combine with AgiiPlus in $578M Deal
by Nicholas Alan Clayton on 2021-10-04 at 12:31pm

Goldenbridge (NASDAQ:GBRG) has entered into a definitive agreement to combine with work solutions provider AgiiPlus at an enterprise value of $578 million, or 10.5x its 2020 revenue.

Shanghai-based AgiiPlus provides flexible office space and software solutions to businesses in China and Singapore.

The combined company is expected to trade on the Nasdaq under the symbol “AGII” once the deal is completed, however the parties have not yet shared a completion timeline.

Transaction Overview

Goldenbridge is funding the deal with $57.5 million from its current trust and aims to arrange a $35 million PIPE to supplement the transaction. AgiiPlus shareholders are to be subject to a one-year lockup, with certain exceptions.

The parties have not yet filed an 8-K or investor presentation, but Goldenbridge’s profile page will be updated once more information on the transaction is made public.


Quick Takes: Agii, which has previously operated under the band name Distrii, provides the equivalent of a B2B WeWork service for companies in Asia that need flexibility in headcount and workspace.

This flexibility came in handy through the pandemic when as its services grew 158% in 2020, generating about $55 million in revenue that year. It currently has about 50 operated sites in service where it has served a total of 7,500 enterprise clients thus far. If a rebound in office work is around the corner as the pandemic ends, Agii appears well positioned.

On one hand, this business model might be coming into its own golden age with the pandemic provoking office workers to demand more flexible arrangements over the long-haul. But, both the Chinese market and co-working spaces in general have not been the most fruitful ground for SPAC transactions in the past.

Ucommune (NASDAQ:UK) completed a business combination with Orisun in November 2020, but has since fallen all the way to $0.84 in its open this morning. Investors are thus far giving much more leeway to BowX (NASDAQ:BOWX) and its pending combination with WeWork, which is of course at a much larger scale but brings its own complications. BowX opened this morning at $9.99.

But, the Asia-Pacific region remains the largest co-working market in the world, and its markets have generally recovered from the pandemic faster than those in North America and Europe. Still, much more information will be needed for investors to have confidence in Agii as it continues through the process.

In the meantime, Agii cuts a high premium to that of WeWork. It is valued in this deal at 10.5x its 2020 revenue while WeWork was valued at about 2.8x. WeWork certainly has other issues involving its debt and liabilities to sort out, but Agii will have to put out more information to assert its superior value as a play.


ADVISORS

  • Goldman Sachs & Co. LLC is acting as financial and capital markets advisor to Amicus Therapeutics.
  • Jefferies LLC is acting as financial advisor and private placement agent to ARYA IV.
  • Skadden, Arps, Slate, Meagher & Flom LLP, Wilson Sonsini Goodrich & Rosati and Troutman Pepper Hamilton Sanders LLP are acting as legal counsel to Amicus Therapeutics.
  • Kirkland & Ellis LLP is acting as legal counsel to ARYA IV.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved